M Gemenetzi
Overview
Explore the profile of M Gemenetzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
302
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gemenetzi M, Lotery A
Cell Mol Life Sci
. 2020 Jan;
77(5):807-818.
PMID: 31897542
The study of epigenetics has explained some of the 'missing heritability' of age-related macular degeneration (AMD). The epigenome also provides a substantial contribution to the organisation of the functional retina....
2.
Gemenetzi M, Lotery A, Patel P
Eye (Lond)
. 2016 Oct;
31(1):1-9.
PMID: 27716750
Anti-vascular endothelial growth factor (VEGF) intravitreal agents are the only successful treatment for wet age-related macular degeneration (AMD). However, there are emerging signals that anti-VEGF treatment can potentially increase development...
3.
Gemenetzi M, Lotery A
Eye (Lond)
. 2015 Oct;
30(1):1-14.
PMID: 26493033
In the age-related macular degeneration (AMD) 'inflammation model', local inflammation plus complement activation contributes to the pathogenesis and progression of the disease. Multiple genetic associations have now been established correlating...
4.
Gemenetzi M, Lotery A
Eye (Lond)
. 2014 Sep;
28(12):1407-17.
PMID: 25233816
It is becoming increasingly evident that epigenetic mechanisms influence gene expression and can explain how interactions between genetics and the environment result in particular phenotypes during development. The extent to...
5.
Gemenetzi M, Lotery A
Eye (Lond)
. 2013 Aug;
27(11):1316-9.
PMID: 23949494
Purpose: To investigate phenotypic variability in terms of best-corrected visual acuity (BCVA) in patients with Stargardt disease (STGD) and confirmed ABCA4 mutations. Methods: Entire coding region analysis of the ABCA4...
6.
Gemenetzi M, Yang Y, Lotery A
Eye (Lond)
. 2011 Dec;
26(3):355-69.
PMID: 22173078
Glaucoma is a common, complex, heterogenous disease and it constitutes the major cause of irreversible blindness worldwide. Primary open-angle glaucoma (POAG) is the most common type of glaucoma in all...
7.
De Salvo G, Gemenetzi M, Luff A, Lotery A
Eye (Lond)
. 2011 Feb;
25(6):821-2.
PMID: 21350572
No abstract available.
8.
Gemenetzi M, De Salvo G, Lotery A
Eye (Lond)
. 2010 Oct;
24(12):1743-56.
PMID: 20930852
Central serous chorioretinopathy (CSC) is a chorioretinal disease, incompletely understood with systemic associations, a multifactorial aetiology, and a complex pathogenesis. Increased permeability from the choriocapillaris leads to focal or diffuse...
9.
Tranos P, Gemenetzi M, Papandroudis A, Chrisafis C, Papadakos D
Eye (Lond)
. 2007 Nov;
22(6):862.
PMID: 18007674
No abstract available.